Cambridge Healthtech Institute’s 10th Annual
Gene Therapy CMC and Analytics
August 18-19, 2025
Cambridge Healthtech Institute’s Gene Therapy CMC and Analytics conference addresses the practical challenges facing the commercialization, characterization, and quality of viral and non-viral-based gene therapies for clinical and commercial supply, with dedicated sessions on CMC strategy, product and process analytics, establishing potency and comparability, capsid engineering, quality control, raw materials, formulation, empty/full, particle analysis detection, stability, and the impact of post-translational modifications (PTMs) on vector safety and quality.
Coverage will include, but is not limited to:
- Commercializing Gene Therapies
- Pricing and Reimbursement
- Analytics—Characterization, Potency, and Comparability
- Next-generation sequencing for advanced therapies
- In vivo engineering of immune cells
- Product-Related Impurities, Structure-Function
- Formulation and Stability of Viral Vectors
The deadline for priority consideration is January 27, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: